Zacks Research Issues Negative Estimate for Danaher Earnings

Danaher Co. (NYSE:DHR) – Investment analysts at Zacks Research cut their Q1 2025 EPS estimates for shares of Danaher in a report issued on Wednesday, February 19th. Zacks Research analyst R. Department now anticipates that the conglomerate will post earnings of $1.62 per share for the quarter, down from their previous estimate of $2.00. The consensus estimate for Danaher’s current full-year earnings is $7.63 per share. Zacks Research also issued estimates for Danaher’s Q4 2025 earnings at $2.36 EPS.

A number of other equities analysts also recently commented on DHR. Guggenheim started coverage on shares of Danaher in a research note on Thursday, December 19th. They set a “buy” rating and a $275.00 price objective for the company. Raymond James reissued a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. JPMorgan Chase & Co. decreased their price target on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Wells Fargo & Company dropped their price objective on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 30th. Finally, Robert W. Baird lowered their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Seven analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average target price of $278.00.

Danaher Trading Down 0.2 %

NYSE DHR opened at $210.65 on Monday. The stock has a market capitalization of $150.56 billion, a price-to-earnings ratio of 39.90, a PEG ratio of 2.66 and a beta of 0.83. The stock’s 50 day moving average price is $225.79 and its two-hundred day moving average price is $246.04. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher has a 52 week low of $196.80 and a 52 week high of $281.70.

Danaher (NYSE:DHR) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the business posted $2.09 EPS.

Hedge Funds Weigh In On Danaher

Several institutional investors and hedge funds have recently modified their holdings of DHR. Norges Bank acquired a new position in shares of Danaher in the fourth quarter valued at about $2,130,740,000. FMR LLC grew its position in Danaher by 15.8% during the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after buying an additional 3,217,631 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in Danaher during the fourth quarter worth approximately $391,172,000. Two Sigma Advisers LP grew its position in Danaher by 4,248.8% during the fourth quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate’s stock worth $376,347,000 after buying an additional 1,601,800 shares in the last quarter. Finally, Capital World Investors grew its position in Danaher by 32.7% during the fourth quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate’s stock worth $1,460,215,000 after buying an additional 1,566,658 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 11.10% of the stock is owned by company insiders.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a $0.32 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.61%. Danaher’s dividend payout ratio is presently 24.24%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.